Northpond Ventures, LP

CIK 1867472 · last filed 2023-06-07

Northpond Ventures, LP is a corporate insider who has filed 3 SEC Form 4 insider transactions across 3 companies since 2021. The most recent filing, for TBIO, was dated Jun 7, 2023. Across all open-market trades the lifetime net is +$62.4M, making them a net buyer over the disclosed history. The firm reports its address in Bethesda, MD. 12 SEC filings were submitted jointly with Northpond Ventures GP, LLC.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

Companies

Total Filings

Lifetime Open-Market Net

$62.35M

Charts

Trading activity, where the exposure sits, and each trade against the stock price.

Filer Profile

Reported Address

7500 OLD GEORGETOWN ROAD
SUITE 800
BETHESDA, MD 20814

Phone

(240) 800-1200

State of Incorporation

Related Filers

Northpond Ventures GP, LLC — 12 joint filings, latest 2024-10-17

Michael P. Rubin — 12 joint filings, latest 2024-10-17

Northpond Ventures GP II, LLC — 8 joint filings, latest 2024-10-17

Northpond Capital, L.P. — 2 joint filings, latest 2021-10-14

Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
Telesis Bio Inc. (TBIO) Delisted	Director	—	$0.00	—	$0	1	2023-06-07
Vigil Neuroscience, Inc. (VIGL) Delisted	10%+ Owner	2,831,520	$8.05	$22.79M	$24.85M	1	2022-01-11
Telesis Bio Inc. (DNAY) Delisted	10%+ Owner	9,375,380	$1.30	$12.19M	$37.50M	1	2021-06-24

Recent Filings

3 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2023-06-07	Telesis Bio Inc. (TBIO) Delisted	Grant (A)	—	$0	EDGAR
2022-01-11	Vigil Neuroscience, Inc. (VIGL) Delisted	Mixed	+21,072,490	$24.85M	EDGAR
2021-06-24	Telesis Bio Inc. (DNAY) Delisted	Mixed	+49,220,650	$37.50M	EDGAR

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.